HomeLYEL • NASDAQ
add
Lyell Immunopharma Inc
Previous close
$0.93
Day range
$0.86 - $1.03
Year range
$0.86 - $3.26
Market cap
250.10M USD
Avg Volume
1.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 13.00K | -51.85% |
Operating expense | 51.54M | -21.83% |
Net income | -45.81M | 28.30% |
Net profit margin | -352.38K | -48.91% |
Earnings per share | — | — |
EBITDA | -46.63M | 23.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 491.12M | -17.56% |
Total assets | 654.14M | -21.69% |
Total liabilities | 87.64M | -11.02% |
Total equity | 566.50M | — |
Shares outstanding | 256.00M | — |
Price to book | 0.42 | — |
Return on assets | -19.11% | — |
Return on capital | -19.95% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -45.81M | 28.30% |
Cash from operations | -38.09M | 2.72% |
Cash from investing | 45.01M | -70.57% |
Cash from financing | 862.00K | -27.93% |
Net change in cash | 7.78M | -93.24% |
Free cash flow | -21.90M | -13.32% |
About
Founded
2018
Headquarters
Website
Employees
224